Prof Subodh Verma (University of Toronto, Toronto, CA) discusses the impact of microvascular disease on cardiorenal outcomes in type 2 diabetes - an analysis from the LEADER and SUSTAIN-6 Clinical Trials.

Filmed on site at ACC 2019 by Radcliffe Cardiology

Videography: Josh Birch

Interviewer: Liam O'Neill